ETHYL (R)-1-BOC-4-OXOPIPERIDINE-2-CARBOXYLATE, 95.0%, 5g

tert-Butyl (1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropyl)carbamate, 95.0%, 250mg

tert-Butyl (3-cyano-4-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-7-fluorobenzo[b]thiophen-2-yl)carbamate, 98%, 100mg

6-Bromoquinolin-4-ol, 95.0%, 500g

3-Bromothioanisole>98.0%(GC)5g

4-(2,6-Dichloro-phenoxymethyl)-benzoic acid, 10g

3,3-Diphenyl-L-alanine, 95.0%, 10g

2-Amino-1-pyridin-3-yl-ethanol, 95.0%, 1g

ethyl 5-(3,4-dimethoxyphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 5g

4-Amino-5-(4-methoxy-phenyl)-4H-[1,2,4]triazole-3-thiol, 95.0%, 250mg

N-(Phenylsulfonyl)-N-((trifluoromethyl)thio)benzenesulfonamide, 50g

Boîte anti-rayonnement SEKUROKA® Antibeta Screens, Midi, 185 x 105 x 80 mm, 1 Pièce

1-(4-Bromophenyl)-1,2,2-triphenylethylene>98.0%(GC)1g